Skip to main content
. 2019 Feb 15;17:3. doi: 10.1186/s12959-019-0192-x

Table 3.

Results of the sensory evaluation questionnaire about edoxaban OD tablets shown by the group

Group 1 (30 mg without water)c N = 32 Group 3 (30 mg with water)d N = 32 Group 2 (60 mg without water)e N = 21 Group 4 (60 mg with water)f N = 21
n (%) n (%) n (%) n (%)
Question 1: Difficulty in ingestion (current) Yes 6 (18.8) 5 (15.6) 2 (9.5) 1 (4.8)
No 26 (81.3) 27 (84.4) 19 (90.5) 20 (95.2)
Question 2: Difficulty in identifying (current) Yes 2 (6.3) 3 (9.4) 0 (0.0) 2 (9.5)
No 30 (93.8) 29 (90.6) 21 (100.0) 19 (90.5)
Question 3: Number of drugs taken simultaneously 1 typea 3 (9.4) 3 (9.4) 1 (4.8) 3 (14.3)
2 types 6 (18.8) 2 (6.3) 4 (19.1) 1 (4.8)
≥3 types 23 (71.9) 27 (84.4) 16 (76.2) 17 (81.0)
Question 4: Degree of satisfaction Unsatisfactory 5 (15.6) 1 (3.1) 7 (33.3) 0 (0.0)
No difference 15 (46.9) 21 (65.6) 6 (28.6) 14 (66.7)
Satisfactory 12 (37.5) 10 (31.3) 8 (38.1) 7 (33.3)
Question 5: Ease in identifying Quite easy 7 (21.9) 7 (21.9) 6 (30.0) 8 (38.1)
Easierb 8 (25.0) 11 (34.4) 7 (35.0) 3 (14.3)
More difficultb 5 (15.6) 3 (9.4) 4 (20.0) 4 (19.1)
Quite difficult 12 (37.5) 11 (34.4) 3 (15.0) 6 (28.6)
Question 6: Size Very large 1 (3.6) 0 (0.0) 0 (0.0) 1 (5.0)
Slightly large 10 (35.7) 19 (61.3) 16 (84.2) 13 (65.0)
Slightly small 16 (57.1) 12 (38.7) 3 (15.8) 6 (30.0)
Very small 1 (3.6) 0 (0.0) 0 (0.0) 0 (0.0)
Question 7: Taste at the time of disintegration Very good 5 (16.7) 5 (20.0) 1 (5.3) 5 (27.8)
Relatively good 16 (53.3) 19 (76.0) 12 (63.2) 12 (66.7)
Relatively bad 9 (30.0) 1 (4.0) 6 (31.6) 1 (5.6)
Very bad 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Question 8: Ease in ingestion (comparison) Quite easy to take 8 (25.0) 8 (25.8) 2 (9.5) 3 (14.3)
Slightly easier to take 6 (18.8) 8 (25.8) 3 (14.3) 5 (23.8)
No difference 9 (28.1) 15 (48.4) 9 (42.9) 12 (57.1)
Slightly more difficult to take 8 (25.0) 0 (0.0) 7 (33.3) 1 (4.8)
Quite difficult to take 1 (3.1) 0 (0.0) 0 (0.0) 0 (0.0)
Question 9: Convenience Much more convenient 7 (21.9) 3 (9.4) 2 (9.5) 6 (28.6)
Slightly more convenient 9 (28.1) 15 (46.9) 6 (28.6) 8 (38.1)
No difference 14 (43.8) 14 (43.8) 13 (61.9) 7 (33.3)
Slightly less convenient 2 (6.3) 0 (0.0) 0 (0.0) 0 (0.0)
Much less convenient 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Question 10: Ease of continuation Much easier to continue 6 (18.8) 2 (6.3) 1 (4.8) 4 (19.1)
Slightly easier to continue 6 (18.8) 13 (40.6) 6 (28.6) 3 (14.3)
No difference 17 (53.1) 17 (53.1) 12 (57.1) 14 (66.7)
Slightly less easy to continue 3 (9.4) 0 (0.0) 2 (9.5) 0 (0.0)
Much less easy to continue 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Question 11: Reliability Much more reliable 2 (6.3) 7 (21.9) 6 (28.6) 6 (28.6)
Slightly more reliable 11 (34.4) 9 (28.1) 5 (23.8) 5 (23.8)
No difference 19 (59.4) 16 (50.0) 10 (47.6) 10 (47.6)
Slightly less reliable 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Much less reliable 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Question 12: Desire to change Desire to change 12 (44.4) 19 (63.3) 6 (30.0) 10 (55.6)
No desire to change 15 (55.6) 11 (36.7) 14 (70.0) 8 (44.4)

aEdoxaban film-coated tablet only

bcompared with the current medication

cedoxaban OD tablet 30 mg without water

dedoxaban OD tablet 30 mg with water

eedoxaban OD tablet 60 mg without water

fedoxaban OD tablet 60 mg with water

OD orally disintegrating